Species: Prevotella denticola (HMT-0291) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0291: [Body Sites Data]
[Taxon Description]
| Life Page: Prevotella denticola
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.11 | 0.05 | 1.18 | 0.01 | 0.03 | 0.01 | 0.10 | 0.07 | 0.09 | 0.04 | 0.01 | 0 | 0 | 0.01 | 0.01 | 0 | 0.13 | 0.02 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.01 | 0 | 0.01 | 0 | 0 | 0.01 | 0.05 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.19 | 0.10 | 3.82 | 0.03 | 0.06 | 0.01 | 0.17 | 0.10 | 0.21 | 0.08 | 0.01 | 0 | 0 | 0.01 | 0.02 | 0.01 | 0.03 | 0.05 |
| Stdev | 0.17 | 0.16 | 2.90 | 0.01 | 0.04 | 0 | 0.06 | 0.04 | 0.09 | 0.03 | 0.02 | 0 | 0 | 0 | 0.02 | 0.01 | 1.21 | 0.06 |
| Prev(%) | 29.17 | 16.96 | 33.33 | 0 | 2.79 | 0 | 12.50 | 0 | 4.55 | 3.55 | 0 | 0 | 0 | 0 | 0 | 0 | 1.06 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to P. denticola and P. multiformis were assigned half to each taxon
reads equally close to P. denticola and P. multiformis were assigned half to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.10 | 0.03 | 0 | 0.01 | 0.01 | 0.02 | 0.03 | 0.12 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.22 | 0.07 | 0 | 0.03 | 0.01 | 0.07 | 0.01 | 0.05 | 0 | 0 |
| Stdev | 0.32 | 0.10 | 0 | 0.02 | 0.05 | 0.04 | 0.25 | 0.54 | 0.01 | 0 |
| Prev(%) | 42.86 | 14.29 | 2.60 | 24.68 | 16.88 | 27.27 | 18.18 | 28.57 | 6.49 | 1.30 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.65 | 0.20 | 0 | 0.07 | 0.05 | 0.14 | 0.07 | 0.38 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.41 | 0.37 | 0 | 0.22 | 0.08 | 0.42 | 0.06 | 0.18 | 0.03 | 0 |
| Stdev | 2.07 | 0.71 | 0.01 | 0.16 | 0.28 | 0.25 | 0.50 | 2.81 | 0.07 | 0 |
| Prev(%) | 51.35 | 32.43 | 4.73 | 44.59 | 28.38 | 58.11 | 23.65 | 33.11 | 16.22 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.14 | 0.04 | 0 | 0 | 0 | 0.04 | 0.04 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0.28 | 0.31 | 0.24 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.38 | 0.09 | 0 | 0 | 0 | 0.15 | 0.03 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.44 | 0.13 | 0 | 0 | 0 | 0.10 | 0.30 | 0.69 | 0 | 0 | 0 | 0 | 0 | 0 | 2.39 | 2.70 | 2.10 | 0 |
| Prev(%) | 46.36 | 21.85 | 0 | 0 | 0 | 35.38 | 19.05 | 28.00 | 0 | 0 | 0 | 0 | 0 | 0 | 1.41 | 2.70 | 1.32 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.38 | 0 | 0 | 0 | 0 | 0.12 | 0 | 0.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0.14 | 0.15 | 0.11 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.76 | 0 | 0 | 0 | 0 | 0.37 | 0 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 1.27 | 0 | 0 | 0 | 0 | 0.22 | 0 | 1.69 | 0 | 0 | 0 | 0 | 0 | 0 | 1.83 | 2.06 | 1.47 | 0 |
| Prev(%) | 50.86 | 0 | 0 | 0 | 0 | 53.87 | 0 | 30.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0.57 | 0.55 | 0.52 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 1.20 | 0.32 | 0.02 | 0.11 | 0.02 | 0.02 | 0.04 | 0.07 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 2.74 | 0.84 | 0.03 | 0.39 | 0.05 | 0.08 | 0.07 | 0.12 | 0.01 | 0 |
| Stdev | 3.46 | 1.03 | 0.08 | 0.20 | 0.03 | 0.04 | 0.11 | 0.22 | 0.01 | 0 |
| Prev(%) | 63.51 | 64.71 | 55.81 | 80.00 | 67.86 | 76.00 | 81.82 | 67.74 | 42.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.09 | 0.05 | 1.38 | 0 | 0.02 | 0 | 0.03 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.20 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.22 | 0.10 | 4.39 | 0 | 0.06 | 0 | 0.09 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.20 | 0.20 | 3.51 | 0.01 | 0.07 | 0 | 0.04 | 0.01 | 0.07 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 2.06 | 0 |
| Prev(%) | 41.67 | 22.98 | 33.33 | 5.88 | 15.96 | 0 | 50.00 | 6.25 | 20.00 | 5.87 | 0 | 0 | 0 | 0 | 0 | 0 | 1.01 | 0 |

